Christopher Schwake

Christopher Schwake, Ph.D., is a Senior Scientist at AstraZeneca, leveraging extensive academic and professional experience in antibody and protein engineering for oncology and infectious disease programs. Previously, at Mersana Therapeutics, they established in-house antibody production capabilities and coordinated antibody discovery efforts, successfully nominating an oncological ADC target. Schwake earned a Ph.D. in Molecular Parasitology from Tufts University, where they developed innovative diagnostic assays and contributed to an NIH grant proposal. Their background also includes a role as Project Coordinator for a clinical trial funded by the Gates Foundation and undergraduate research at Bucknell University.